2[2]Hark W, Kaste M, Bogousslavsky J, et al. The European Stroke Initiative Recommendations for Stroke Management-update 2003.Cerebrovasc Dis, 2003, 16:311-337.
3[3]Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update.Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 2002, 106:388-391.
4[5]PROGRESS Collaborative Group. Randomised trial of a perindoprilbased blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet, 2001, 358:1033-1041.
5[6]Blood Pressure in Acute Stroke Collaboration. Interventions for deliberately altering blood pressure in acute stroke. The Cochrane Library. 2002, issue 2.
6[7]Schrader J, Luders S, Kulschewski A, et al. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke, 2003, 34:1699-1703.
7[8]Semplicini A, Maresca A, Boscolo G, et al. Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med, 2003, 163:211-216.
8[9]Leonardi-Bee J, Bath PM, Phillips S J, et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke, 2002, 33:1315-1320.
9[10]Adams HP Jr, Adams RJ, Brott T, et al. Guideline for the early management of patients with ischemic stroke: a scientific statement from the stroke Council of the American Stroke Association. Stroke,2003, 34:1056-1083.
10[11]Sackett DL, Straus SE, Richardson WS, eds. Evidence-based medicine: how to practice and teach EBM. 2nd ed. London:Churchill Livingstone, 2000. 105-182.
二级参考文献8
1PROGRESS Collaborative Group. Randomised trial of a pefindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet, 2001, 358:1033-1041.
2Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects in individuals and populations.Lancet, 1999,354 : 1457-1463.
3Adams HP, del Zoppo GJ, yon Kummer R. Management of stroke.2^nd ed. New York :Professional Communications Inc, 2002. 25-50.
4Warlow CP, Dennis MS, van Gijn J, et al. Stroke : a practical guide to management. 2nd ed. Oxford : Blackwell Science, 2001. 762-784.
5Goldstein LB, Adams CR, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association. Stroke, 2001,32 :280-299.
6Pearson TA, Steve NB, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation ,2002,106:388-391.
1Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke, 2002, 33:1315-1320.
2Castillo J, Leira R, Garcia MM, et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke, 2004, 35:520-526.
3Ahmed N, Wahlgren N, Brainin M, et al. Relationship of hlood pressure, antihypertensive therapy, and outcome in isehemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke- International Stroke Thrombolysis Register (SITS-ISTR). Stroke, 2009, 40:2442-2449.
4Perini F, De Boni A, Marcon M, et al. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke. J Neurol Sci, 2010, 297(1/2):52-54.
5Schrader J, Luders S, Katschewski A, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Tllerapy in Stroke Survivors. Stroke, 2003, 34:1699-1703.
6Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens, 2007, 20:270-277.
7Bath PM, Martin RH, Palesch Y, et al. Effect of tehnisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PROFESS subgroup analysis. Stroke, 2009, 40:5541-5546.
8Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post - stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol, 2009, 8:48-56.
9Robinson TG, Potter iF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post - Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol, 2010, 9:767-775.
10Shanbrom E, Levy L. The role of systemic blood pressure in cerebral circulation in carotid and basilar artery thrombosis;clinical observations and therapeutic implications of vasopressor agents. Am J Med. 1957, 23:197-204.
